Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
Mariko Yoshida(Kanazawa University), Shuichi Kaneko(Kanazawa University Hospital)
Cited by 34
Related Papers
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
|Journal of Hepatology|2013|143
Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo
|Scientific Reports|2017|35
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma
|Molecular Oncology|2021|29